Matthew P. Goetz

2002–2026 年に発表

164
論文数
29,721
被引用数
80
h 指数
155
i10 指数

被引用数

Matthew P. Goetz の年別被引用数1964 年: 被引用 1 件1981 年: 被引用 1 件1995 年: 被引用 1 件2001 年: 被引用 1 件2003 年: 被引用 2 件2004 年: 被引用 15 件2005 年: 被引用 41 件2006 年: 被引用 44 件2007 年: 被引用 107 件2008 年: 被引用 106 件2009 年: 被引用 124 件2010 年: 被引用 109 件2011 年: 被引用 107 件2012 年: 被引用 103 件2013 年: 被引用 96 件2014 年: 被引用 105 件2015 年: 被引用 99 件2016 年: 被引用 79 件2017 年: 被引用 111 件2018 年: 被引用 161 件2019 年: 被引用 844 件2020 年: 被引用 1,064 件2021 年: 被引用 1,199 件2022 年: 被引用 1,069 件2023 年: 被引用 952 件2024 年: 被引用 1,733 件2025 年: 被引用 888 件2026 年: 被引用 26 件1965〜1980 年は被引用が無いため表示していません1982〜1994 年は被引用が無いため表示していません1996〜2000 年は被引用が無いため表示していません2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,160 件、この内訳の 24.9%中国: 引用元論文 1,637 件、この内訳の 12.9%イタリア: 引用元論文 775 件、この内訳の 6.1%イギリス: 引用元論文 631 件、この内訳の 5%ドイツ: 引用元論文 563 件、この内訳の 4.4%フランス: 引用元論文 468 件、この内訳の 3.7%カナダ: 引用元論文 447 件、この内訳の 3.5%スペイン: 引用元論文 416 件、この内訳の 3.3%オーストラリア: 引用元論文 334 件、この内訳の 2.6%韓国: 引用元論文 299 件、この内訳の 2.4%スイス: 引用元論文 286 件、この内訳の 2.3%ベルギー: 引用元論文 284 件、この内訳の 2.2%
0%24.9%その他 26.7%

分野

  • Medicine51.8%
  • Biochemistry, Genetics and Molecular Biology38.2%
  • Pharmacology, Toxicology and Pharmaceutics3.1%
  • Computer Science2%
  • Immunology and Microbiology1.5%
  • Engineering1.2%
  • その他2.2%

トピック

  • Breast Cancer Treatment Studies9.2%
  • Advanced Breast Cancer Therapies6.7%
  • HER2/EGFR in Cancer Research4.9%
  • Cancer-related Molecular Pathways2.6%
  • Cancer Genomics and Diagnostics2.6%
  • Breast Lesions and Carcinomas2.4%
  • その他71.6%

共著者

全論文

検索で開く
  1. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 2,369

  2. MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 1,717

  3. Advances in systemic therapies for triple negative breast cancer

    著者: , - BMJ 2023 被引用: 465

  4. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2022 被引用: 566

  5. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Kari B. Wisinski, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2022 被引用: 964

  6. NCCN Guidelines® Insights: Breast Cancer, Version 4.2023

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melinda L. Telli, Mei Wei, Kari B. Wisinski, Jessica Young, Kay T. Yeung, Mary A. Dwyer, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2023 被引用: 440

  7. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melinda L. Telli, John H. Ward, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2020 被引用: 1,618

  8. openalex_id:w4200350191

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen‐John Sammut, Jeremy Thomas, David Cameron, A Graham, Peter S Hall, Lorna Mackintosh, Fang Fan, Andrew K. Godwin, Kelsey Schwensen, Priyanka Sharma, Angela DeMichele, Kimberly Cole, Lajos Pusztai, Mi‐Ok Kim, Laura van ‘t Veer, Laura Esserman, W. Fraser Symmans, Kathi Adamson, Kathy S. Albain, Adam L. Asare, Smita Asare, Ronald Balassanian, Heather Beckwith, Scott Berry, Donald A. Berry, Meredith Buxton, Yunn‐Yi Chen, Beiyun Chen, A. Jo Chien, Jane Yuet Ching Hui, Amy S. Clark, Julia L. Clennell, Brian Datnow, Xiuzhen Duan, Kirsten K. Edmiston, Anthony Elias, Erin D. Ellis, David Euhus, Oluwole Fadare, Michael D. Feldman, Andres Forero‐Torres, Barbara Haley, Hyo S. Han, Shuko Harada, Patricia Haugen, Teresa Helsten, Gillian L. Hirst, Nola M. Hylton, Claudine Isaacs, Kathleen Kemmer, Qamar J. Khan, Laila Khazai, Molly Klein, Gregor Krings, Julie E. Lang, Lauren LeBeau, Brian Leyland‐Jones, Minetta C. Liu, Shelly S. Lo, Janice Lu, Anthony M. Magliocco, Jeffrey B. Matthews, Michelle Melisko, Paulette Mhawech‐Fauceglia, Stacy L. Moulder, Rashmi K. Murthy, Rita Nanda, Donald W. Northfelt, Idris Tolgay Ocal, Olufunmilayo I. Olopade ほか 28 名 被引用: 353

  9. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

    著者: , , , , , , , , , , , , - npj Breast Cancer 2019 被引用: 676

  10. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, Mei Wei, Kari B. Wisinski, Kay T. Yeung, Jessica Young, Ryan Schonfeld, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2024 被引用: 560

  11. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Belén San Antonio, Sarah C. Nabinger, Masakazu Toi, Stephen Johnston, Joyce O’Shaughnessy, M.M. Jimenez, Stephen Johnston, F. Boyle, Guenther G. Steger, Patrick Neven, Zefei Jiang, Mario Campone, Jens Huober, Chikako Shimizu, I. Cicin, Andrew Wardley, Sara M. Tolaney, Gonzalo Gómez Abuin, J. J. Zarba, Elgene Lim, P. Sant, Naishun Liao, Bo Christiansen, Natalja Eigėlienė, J. Martin-Babau, Johannes Ettl, D. Mavroudis, Joanne Chiu, Katalin Boér, R. Nagarkar, Shani Paluch–Shimon, Luca Moscetti, Yoshiatsu Sagara, S.-B. Kim, Rui M. B. Maciel, Vivianne C. G. Tjan‐Heijnen, Reuben Broom, Aleksandra Łacko, M. Schenker, Nikita Volkov, Yoon Sim Yap, M.A. Coccia-Portugal, J. Ángel García Sáenz, Anne Andersson, Tai-Jong Chao, Erhan Gökmen, Hakan Harputluoğlu, O. Berzoy, Debra A. Patt, Heather L. McArthur, Helen K. Chew, Pavani Chalasani, Peter A. Kaufman, Karen L. Tedesco, Stephanie L. Graff - Annals of Oncology 2021 被引用: 378

  12. Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2024 被引用: 204

  13. Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies

    著者: , , , , , , , , , , , , , , , - Cancers 2020 被引用: 340

  14. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Ruepp, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan - New England Journal of Medicine 2018 被引用: 673

  15. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sabine C. Linn, Matthew P. Goetz, Stefan Michiels, International Immuno-Oncology Biomarker Working Group - JAMA 2024 被引用: 199

  16. Carnitine Palmitoyltransferase 1A Has a Lysine Succinyltransferase Activity

    著者: , , , , , , , , - Cell Reports 2018 被引用: 194

  17. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 154

  18. Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 555

  19. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jon Godwin, Sam James, Amanda Kerr, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Mariko Nakahara, Simon Read, Hannah Taylor, John Ferguson, H Scheurlen, Stefano Zurrida, Viviana Galimberti, James N. Ingle, Pinuccia Valagussa, Umberto Veronesi, Stewart Anderson, Gong Tang, Bernard Fisher, Sophie D. Fosså, Kristin V. Reinertsen, Herman Høst, Hyman B. Muss, Kaija Holli, Kathy S. Albain, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, José Á. García-Sáenz, Rich Gelber, Michael Gnant, Matthew P. Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Stuart McIntosh, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Martine Piccart, Lori J. Pierce, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Roberto Salgado, Dennis J. Slamon, Tanja Španić ほか 14 名 - The Lancet 2023 被引用: 151

  20. Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Miguel Gil‐Gil, Aleix Prat, Hannes Fohler, Otto Metzger, Magdalena Schwarz, Carter DuFrane, Debora Fumagalli, Kathy Puyana Theall, Dongrui R. Lu, Cynthia Huang Bartlett, María Koehler, Christian Fesl, Angela DeMichele, Michael Gnant - The Lancet Oncology 2021 被引用: 255

  21. NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , María Koehler, Hussam Al‐Kateb, Souzan Sanati, Matthew J. Ellis - Clinical Cancer Research 2017 被引用: 376

  22. Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3

    著者: , , , , , , , , - The Oncologist 2020 被引用: 172

  23. A comprehensive analysis of breast cancer microbiota and host gene expression

    著者: , , , , , , , , , , , , , , , , , - PLoS ONE 2017 被引用: 179

  24. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010

    著者: , , , , , , , , , , , , - JAMA Network Open 2023 被引用: 97